Heartfulness Meditation and Corporate Burnout

September 30, 2021 updated by: Resolution Blue Labs Inc

Effect of Heartfulness Corporate Wellness Program on Burnout Inventory Measurements

The purpose of this study is to evaluate the effect of a 4-week heart-based meditation practice wellness workshop on burnout and emotional wellness in corporate employees. Corporate employees can be defined as individuals who work in large institutions with greater than 300 employees.

The specific aim of this study is to assess changes in scores measuring symptoms of emotional exhaustion, depersonalization, and personal accomplishment using the Maslach Burnout Index. We hypothesize that the meditation wellness practice will be associated with reduction in burnout for those who take part in the meditation program in comparison to the participants who did not meditate and participate in the wellness program.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Canada
    • Ontario
      • Toronto, Ontario, Canada, M1T1P2

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population is reflective of the general population, who work in large corporations and have self-identified as having moderate to high levels of stress.

Description

Inclusion Criteria:

  • Adults above 18 years of age willing to participate in the study.

Exclusion Criteria:

  • Individuals less than 18 years of age, active suicidal ideation, current or past diagnoses of serious psychotic disorders- schizophrenia, personality disorders and post-traumatic stress disorder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control
Participate in filling the questionnaire but NOT the meditation/wellness session (control).
Wellness Group
Participate in filling the questionnaire and the meditation/wellness session
Other: Heartfulness Meditation
A four-week Heartfulness Wellness seminar, where people are exposed to Heartfulness Meditation and its meditation tools. Participants experience: Heartfulness Guided Relaxation, Heartfulness Meditation and Heartfulness Unwinding/Rejuvenation Technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in Burnout Scores
Time Frame: Week 0 & Week 4
Assess the difference in burnout scores between both groups at week 0 and week 4.
Week 0 & Week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in in scores measuring symptoms of emotional exhaustion, depersonalization, and personal accomplishment, using the Maslach Burnout Inventory.
Time Frame: Week 0 & Week 4
Assess the difference in specific symptoms scores between both groups at week 0 and week 4.
Week 0 & Week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Resolution Blue Labs Inc

Collaborators

Heartfulness Institute

Investigators

  • Principal Investigator: Andy Kumar, MD/PhD Candidate, Resolution Blue Labs Inc
  • Principal Investigator: Aravindhan Ravindhran, MD, Resolution Blue Labs Inc
  • Principal Investigator: Arth Patel, MD Candidate, Resolution Blue Labs Inc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2021

Primary Completion (ANTICIPATED)

April 30, 2022

Study Completion (ANTICIPATED)

July 1, 2022

Study Registration Dates

First Submitted

July 9, 2021

First Submitted That Met QC Criteria

July 9, 2021

First Posted (ACTUAL)

July 20, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 8, 2021

Last Update Submitted That Met QC Criteria

September 30, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RBL-X Wellness_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe